Nektar Therapeutics Faces Class Action Over Misleading Trial Claims
Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial integrity. Investors urged to join by May 5, 2026 deadline.
NKTRsecurities fraudclass action lawsuit